← Leaderboards
Shawna Nicole Smith
University Of Michigan At Ann Arbor
$1,422,649
Attributed
$3,594,004
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,246,118 · 1
AHRQ$1,347,886 · 1
By mechanism
R01$2,246,118 · 1
R18$1,347,886 · 1
Top collaborators
- Geoffrey Douglas Barnes6 shared
- Colin Fred Greineder3 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Alan P Boyle$9,857,541
- Jenna Wiens$3,682,281
- Michael William Sjoding$3,582,183
- Ted Albert Skolarus$3,689,953
- Jeffrey S Chamberlain$54,800,495
Others in their field
Other Emerging Leaders on “Acute”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$51,003,204
- Julie Ake · National Institute Of Allergy And Infectious Diseases$41,692,120
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
Research focus
AcuteAdherenceAdmission ActivityAdoptionAdverse EventAmbulatory CareAmericanAnticoagulantsBehavioral EconomicsBehavioral SciencesBehavior ChangeCare DeliveryCaringClinical Decision-MakingClinical PracticeConflict (Psychology)Data CollectionDecision MakingDesignDiagnosisDisparityEffectivenessEffectiveness StudyAccident And Emergency Department
Grant awards (6)
Michigan Emergency Department Improvement Collaborative AltERnaTives to admission for Pulmonary Embolism (MEDIC ALERT PE) Study$774,699
R01 · FY2025 · HL
Michigan Emergency Department Improvement Collaborative AltERnaTives to admission for Pulmonary Embolism (MEDIC ALERT PE) Study$763,210
R01 · FY2024 · HL
Michigan Emergency Department Improvement Collaborative AltERnaTives to admission for Pulmonary Embolism (MEDIC ALERT PE) Study$708,209
R01 · FY2023 · HL
Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use$448,896
R18 · FY2023 · HS
Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use$448,991
R18 · FY2022 · HS
Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use$449,999
R18 · FY2021 · HS